ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter

Lupin to buy branded drugs from Shionogi in Japan expansion

 (placeholder image)
An employee of Lupin works at a reception at their headquarters in Mumbai.   © Reuters

MUMBAI (NewsRise) -- Lupin, India's third-largest drug maker, has agreed to buy 21 branded products from Japan's Shionogi & Co. for 15.4 billion yen ($151 million), as it seeks to expand its overseas business amid rising competition in the generics medicine market.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more